PT2327407E - Agentes profiláticos e/ou terapêuticos para desordens gastrointestinais funcionais - Google Patents
Agentes profiláticos e/ou terapêuticos para desordens gastrointestinais funcionais Download PDFInfo
- Publication number
- PT2327407E PT2327407E PT98161664T PT09816166T PT2327407E PT 2327407 E PT2327407 E PT 2327407E PT 98161664 T PT98161664 T PT 98161664T PT 09816166 T PT09816166 T PT 09816166T PT 2327407 E PT2327407 E PT 2327407E
- Authority
- PT
- Portugal
- Prior art keywords
- prophylactic
- therapeutic agent
- gastrointestinal disorders
- functional gastrointestinal
- functional
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008248932 | 2008-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2327407E true PT2327407E (pt) | 2014-09-10 |
Family
ID=42059749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98161664T PT2327407E (pt) | 2008-09-26 | 2009-09-24 | Agentes profiláticos e/ou terapêuticos para desordens gastrointestinais funcionais |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8980872B2 (pt) |
| EP (1) | EP2327407B1 (pt) |
| JP (1) | JP5567484B2 (pt) |
| KR (1) | KR20110071096A (pt) |
| CN (1) | CN102164599B (pt) |
| AU (1) | AU2009297562B2 (pt) |
| BR (1) | BRPI0918997A2 (pt) |
| CA (1) | CA2736285C (pt) |
| DK (1) | DK2327407T3 (pt) |
| ES (1) | ES2496190T3 (pt) |
| PL (1) | PL2327407T3 (pt) |
| PT (1) | PT2327407E (pt) |
| RU (1) | RU2011116400A (pt) |
| WO (1) | WO2010035751A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| CA2778181A1 (en) | 2009-10-26 | 2011-05-05 | Thomas Julius Borody | Therapy for enteric infections |
| US11825856B2 (en) | 2018-03-28 | 2023-11-28 | Morinaga Milk Industry Co., Ltd. | Composition for preventing or improving functional gastrointestinal disorders, and, pharmaceutical composition, food/beverage composition, and method of preventing or improving functional gastrointestinal disorders using the composition for preventing or improving functional gastrointestinal disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| JPS6123192A (ja) | 1984-07-11 | 1986-01-31 | 三菱電機株式会社 | マトリクス型表示装置の製造方法 |
| IT1253711B (it) | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali |
| IT1264494B1 (it) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| IT1290679B1 (it) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| ES2522895T3 (es) | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
| WO2006102536A2 (en) * | 2005-03-23 | 2006-09-28 | University Of Southern California | Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| EP1996710B1 (en) * | 2006-03-09 | 2019-08-14 | Salix Pharmaceuticals, Inc. | Rifaximin anti-rectal dysfunction preparation |
| AU2007281413B2 (en) * | 2006-08-02 | 2013-10-31 | Christopher Jahraus | Compositions and methods for the treatment of radiation proctosigmoiditis |
-
2009
- 2009-09-24 CN CN200980137540.1A patent/CN102164599B/zh active Active
- 2009-09-24 US US13/061,239 patent/US8980872B2/en active Active
- 2009-09-24 PL PL09816166T patent/PL2327407T3/pl unknown
- 2009-09-24 AU AU2009297562A patent/AU2009297562B2/en active Active
- 2009-09-24 EP EP09816166.4A patent/EP2327407B1/en active Active
- 2009-09-24 BR BRPI0918997A patent/BRPI0918997A2/pt not_active Application Discontinuation
- 2009-09-24 CA CA2736285A patent/CA2736285C/en active Active
- 2009-09-24 PT PT98161664T patent/PT2327407E/pt unknown
- 2009-09-24 ES ES09816166.4T patent/ES2496190T3/es active Active
- 2009-09-24 KR KR1020117009342A patent/KR20110071096A/ko active Search and Examination
- 2009-09-24 DK DK09816166.4T patent/DK2327407T3/da active
- 2009-09-24 WO PCT/JP2009/066533 patent/WO2010035751A1/ja active Application Filing
- 2009-09-24 RU RU2011116400/15A patent/RU2011116400A/ru unknown
- 2009-09-24 JP JP2010530854A patent/JP5567484B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2736285A1 (en) | 2010-04-01 |
| JP5567484B2 (ja) | 2014-08-06 |
| EP2327407A1 (en) | 2011-06-01 |
| WO2010035751A1 (ja) | 2010-04-01 |
| ES2496190T3 (es) | 2014-09-18 |
| US8980872B2 (en) | 2015-03-17 |
| KR20110071096A (ko) | 2011-06-28 |
| PL2327407T3 (pl) | 2014-12-31 |
| BRPI0918997A2 (pt) | 2015-12-01 |
| US20110152517A1 (en) | 2011-06-23 |
| AU2009297562A1 (en) | 2010-04-01 |
| EP2327407B1 (en) | 2014-07-09 |
| CN102164599B (zh) | 2014-07-23 |
| DK2327407T3 (da) | 2014-08-25 |
| EP2327407A4 (en) | 2012-02-29 |
| CN102164599A (zh) | 2011-08-24 |
| AU2009297562B2 (en) | 2015-04-23 |
| JPWO2010035751A1 (ja) | 2012-02-23 |
| RU2011116400A (ru) | 2012-11-10 |
| CA2736285C (en) | 2016-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2308493A4 (en) | ENHANCING OR THERAPEUTIC AGENT FOR DYSLIPIDEMIA | |
| EP2198869A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION | |
| EP2269646A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | |
| IL201018A0 (en) | Novel asparaginases and uses thereof | |
| EP2156846A4 (en) | PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST DIARRHEA | |
| EP1996218A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | |
| AU318442S (en) | Footbath | |
| EP2434010A4 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT FOR THE METABOLIC SYNDROME | |
| EP2004216A4 (en) | AGENT FOR THE TREATMENT OF HORMONO-DEPENDENT DISORDERS AND USES THEREOF | |
| ZA201007362B (en) | Conjugates for the treatment of mesothelioma | |
| ZA201000225B (en) | Treatment of depression | |
| PL2151240T3 (pl) | Środek terapeutyczny lub profilaktyczny przeciw dyskinezie | |
| ZA201103627B (en) | Prophylactic/therapeutic agent for cancer | |
| GB0702537D0 (en) | Treatment for excessive adiposity | |
| HK1158108A1 (en) | Therapeutic or prophylactic agent for generalized pain syndrome | |
| EP2285398A4 (en) | METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS | |
| GB0900484D0 (en) | Therapeutic agent | |
| EP2123284A4 (en) | PREVENTIVE AND / OR THERAPEUTIC ACTIVE INGREDIENTS FOR HEART INFARS | |
| PL2327407T3 (pl) | Środek profilaktyczny i/lub terapeutyczny na zaburzenia czynnościowe przewodu pokarmowego | |
| EP2500020A4 (en) | THERAPEUTIC OR PROPHYLACTIC ACTIVE AGAINST DIABETES | |
| HK1138204A1 (en) | Prophylactic or therapeutic agent for alopecia | |
| EP2123642A4 (en) | NEW PROPHYLACTIC AND / OR THERAPEUTIC AGENT AGAINST NEUROGENIC PAIN | |
| EP2140876A4 (en) | THERAPEUTIC AGENT COMPRISING VASOHIBINE | |
| EP2455077A4 (en) | PROPHYLACTIC AND / OR THERAPEUTIC AGENT FOR DYSMENORRHEA | |
| GB0909944D0 (en) | Therapeutic agent and assay |